- JP-listed companies
- Chordia Therapeutics,Inc
Chordia Therapeutics,IncJP:190A
Market cap
¥27.2B
P/E ratio
121.6x
Aug 31, 2022 | Aug 31, 2023 | |
Business revenue | - | 2,500 |
Research and development expense | 1,656 | 1,997 |
Selling, general and administrative expenses | 188 | 291 |
Business expenses | 1,844 | 2,288 |
Operating profit (loss) | -1,844 | 212 |
Compensation Income for transfer | 54 | 17 |
Subsidy income | 39 | 8 |
Subsidy income | 39 | 8 |
Other | 2 | 1 |
Other | 2 | 1 |
Non-operating income | 95 | 26 |
Non-operating income | 95 | 26 |
Share issuance costs | 25 | - |
Foreign exchange losses | 3 | 12 |
Foreign exchange losses | 3 | 12 |
Non-operating expenses | 27 | 12 |
Other | 0 | - |
Non-operating expenses | 27 | 12 |
Ordinary profit (loss) | -1,777 | 226 |
Profit (loss) before income taxes | -1,777 | 226 |
Income taxes - current | 2 | 2 |
Income taxes | 2 | 2 |
Profit (loss) | -1,779 | 223 |